268 related articles for article (PubMed ID: 10189947)
21. Anti-HIV activity against immunodeficiency virus type 1 (HIV-I) and type II (HIV-II) of compounds isolated from the stem bark of Combretum molle.
Asres K; Bucar F
Ethiop Med J; 2005 Jan; 43(1):15-20. PubMed ID: 16370525
[TBL] [Abstract][Full Text] [Related]
22. HIV protease inhibitory bis-benzamide cyclic ureas: a quantitative structure-activity relationship analysis.
Wilkerson WW; Akamike E; Cheatham WW; Hollis AY; Collins RD; DeLucca I; Lam PY; Ru Y
J Med Chem; 1996 Oct; 39(21):4299-312. PubMed ID: 8863807
[TBL] [Abstract][Full Text] [Related]
23. [In vitro pharmacodynamics study of an anti-HIV Chinese herbal formulation].
Li ZL; Zeng Y; Su LS; Zhang XM; Shao YM; Zeng X; Wolf H; Zeng Y
Yao Xue Xue Bao; 2010 Feb; 45(2):253-6. PubMed ID: 21351436
[TBL] [Abstract][Full Text] [Related]
24. Screening of selected plant extracts for in vitro inhibitory activity on HIV-1 reverse transcriptase (HIV-1 RT).
Mlinaric A; Kreft S; Umek A; Strukelj B
Pharmazie; 2000 Jan; 55(1):75-7. PubMed ID: 10683878
[TBL] [Abstract][Full Text] [Related]
25. Inhibitory activities of selected Sudanese medicinal plants on Porphyromonas gingivalis and matrix metalloproteinase-9 and isolation of bioactive compounds from Combretum hartmannianum (Schweinf) bark.
Mohieldin EAM; Muddathir AM; Mitsunaga T
BMC Complement Altern Med; 2017 Apr; 17(1):224. PubMed ID: 28427461
[TBL] [Abstract][Full Text] [Related]
26. A survey of some Indian medicinal plants for anti-human immunodeficiency virus (HIV) activity.
Premanathan M; Rajendran S; Ramanathan T; Kathiresan K; Nakashima H; Yamamoto N
Indian J Med Res; 2000 Sep; 112():73-7. PubMed ID: 11094851
[TBL] [Abstract][Full Text] [Related]
27. Screening of selected plant extracts for in vitro inhibitory activity on human immunodeficiency virus.
Bedoya LM; Palomino SS; Abad MJ; Bermejo P; Alcami J
Phytother Res; 2002 Sep; 16(6):550-4. PubMed ID: 12237813
[TBL] [Abstract][Full Text] [Related]
28. Korean medicinal plants inhibiting to human immunodeficiency virus type 1 (HIV-1) fusion.
Chang YS; Woo ER
Phytother Res; 2003 Apr; 17(4):426-9. PubMed ID: 12722157
[TBL] [Abstract][Full Text] [Related]
29. Inhibitory effects of sudanese medicinal plant extracts on hepatitis C virus (HCV) protease.
Hussein G; Miyashiro H; Nakamura N; Hattori M; Kakiuchi N; Shimotohno K
Phytother Res; 2000 Nov; 14(7):510-6. PubMed ID: 11054840
[TBL] [Abstract][Full Text] [Related]
30. Screening of Korean plants against human immunodeficiency virus type 1 protease.
Min BS; Bae KH; Kim YH; Miyashiro H; Hattori M; Shimotohno K
Phytother Res; 1999 Dec; 13(8):680-2. PubMed ID: 10594938
[TBL] [Abstract][Full Text] [Related]
31. Effects of triterpenoids and flavonoids isolated from Alnus firma on HIV-1 viral enzymes.
Yu YB; Miyashiro H; Nakamura N; Hattori M; Park JC
Arch Pharm Res; 2007 Jul; 30(7):820-6. PubMed ID: 17703732
[TBL] [Abstract][Full Text] [Related]
32. Anti-HIV-1 protease activity of compounds from Boesenbergia pandurata.
Cheenpracha S; Karalai C; Ponglimanont C; Subhadhirasakul S; Tewtrakul S
Bioorg Med Chem; 2006 Mar; 14(6):1710-4. PubMed ID: 16263298
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of HIV-1 protease and RNase H of HIV-1 reverse transcriptase activities by long chain phenols from the sarcotestas of Ginkgo biloba.
Lee JS; Hattori M; Kim J
Planta Med; 2008 Apr; 74(5):532-4. PubMed ID: 18543149
[TBL] [Abstract][Full Text] [Related]
34. Anti-HIV-1 activities in extracts from some medicinal plants as assessed in an in vitro biochemical HIV-1 reverse transcriptase assay.
Kanyara JN; Njagi EN
Phytother Res; 2005 Apr; 19(4):287-90. PubMed ID: 16041768
[TBL] [Abstract][Full Text] [Related]
35. In Vivo antimalarial activity of aqueous extracts from Kenyan medicinal plants and their chloroquine (CQ) potentiation effects against a blood-induced CQ-resistant rodent parasite in mice.
Muregi FW; Ishih A; Suzuki T; Kino H; Amano T; Mkoji GM; Miyase T; Terada M
Phytother Res; 2007 Apr; 21(4):337-43. PubMed ID: 17221829
[TBL] [Abstract][Full Text] [Related]
36. Anti-parasitic activity and cytotoxicity of selected medicinal plants from Kenya.
Kigondu EV; Rukunga GM; Keriko JM; Tonui WK; Gathirwa JW; Kirira PG; Irungu B; Ingonga JM; Ndiege IO
J Ethnopharmacol; 2009 Jun; 123(3):504-9. PubMed ID: 19501282
[TBL] [Abstract][Full Text] [Related]
37. Hypoglycemic, anticomplement and anti-HIV activities of Spathodea campanulata stem bark.
Niyonzima G; Laekeman G; Witvrouw M; Van Poel B; Pieters L; Paper D; De Clercq E; Franz G; Vlietinck AJ
Phytomedicine; 1999 Mar; 6(1):45-9. PubMed ID: 10228611
[TBL] [Abstract][Full Text] [Related]
38. In vitro ACE inhibitory effects of some Bangladeshi plant extracts.
Khan MT; Matsui T; Matsumoto Y; Jabbar S
Pharmazie; 2001 Nov; 56(11):902-3. PubMed ID: 11817183
[No Abstract] [Full Text] [Related]
39. Molluscicidal properties of Acacia nilotica subspecies tomentosa and astringens II.
Hussein Ayoub SM
J Trop Med Hyg; 1985 Jun; 88(3):201-3. PubMed ID: 4068077
[TBL] [Abstract][Full Text] [Related]
40. Novel P1 chain-extended HIV protease inhibitors possessing potent anti-HIV activity and remarkable inverse antiviral resistance profiles.
Miller JF; Brieger M; Furfine ES; Hazen RJ; Kaldor I; Reynolds D; Sherrill RG; Spaltenstein A
Bioorg Med Chem Lett; 2005 Aug; 15(15):3496-500. PubMed ID: 15990305
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
